Search

Learn why Black men should be especially mindful of prostate cancer risk.

… Friday, January 17, 2025 Cancer does not discriminate, except when it does.  Prostate cancer  takes a harsher toll on Black men than other American men. Black men are almost 70% more likely than white men to develop prostate cancer in their lifetime and twice as likely to die from the disease, according

With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer.

… Tuesday, May 20, 2014 Summary With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer. We are thrilled to announce the creation

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Tuesday, February 22, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Tomya Watt Named to Crain’s New York Business Notable Black Leaders 2022 List Tomya Watt Tomya Watt , Chief Diversity Officer and Vice President of Talent Acquisition and Mobility,

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31–June 4, in Chicago.

… Thursday, May 23, 2024 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31

Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.

… Wednesday, February 20, 2013 Summary Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research. Charles L. Sawyers , Chair of Memorial Sloan Kettering’s Human Oncology

Researchers from MSK are leading the effort to develop artificial intelligence tools for the detection of the most serious form of skin cancer.

… Thursday, July 15, 2021 Melanoma is by far the most serious form of skin cancer. It’s diagnosed in about 105,000 people in the United States every year, and more than 7,000 Americans die from it annually. But when it’s caught and treated early, the disease is almost always curable. That’s why it’s important

When we talk about cancer, we often speak about “battling” or “fighting” it, writes psychiatrist William Breitbart. But a more useful mindset may focus less on combat and more on bravery, especially the courage to live, love, and care, despite the disease.

… Wednesday, August 2, 2017 Summary Cancer is not a single disease. And there is no single way to talk about it, whether the conversation is taking place around the family dinner table or roaring across the television screen. But some ways of thinking and talking about cancer can be more helpful than others

As the height of the COVID-19 outbreak in New York City and the Tri-State area begins to subside, oncologists at Memorial Sloan Kettering Cancer Center (MSK) are urging patients to schedule cancer screenings and treatments now.

… Tuesday, May 26, 2020 As the height of the COVID-19 outbreak in New York City and the Tri-State area begins to subside, oncologists at Memorial Sloan Kettering Cancer Center (MSK) are urging patients to schedule cancer screenings and treatments now – as the long-term toll of missed diagnoses and delayed

Andrew L. Kung, MD, PhD, has been named the new Chairman of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center (MSK). An accomplished physician, researcher, leader, and mentor, Dr. Kung most recently served as the Chief of the Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation at New York-Presbyterian/Morgan Stanley Children’s Hospital and Columbia University Medical Center (CUMC). Dr. Kung formally assumes his new role as Richard J. O’Reilly, MD, steps down as Chairman after more than 30 years.

… Monday, June 20, 2016 Andrew L. Kung, MD, PhD, has been named the new Chairman of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center (MSK). An accomplished physician, researcher, leader, and mentor, Dr. Kung most recently served as the Chief of the Division of Pediatric Hematology

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Friday, January 22, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Craig B. Thompson Named to City and State’s 2021 Health Power 100 List Craig B. Thompson, MD Craig Thompson, MD, President and CEO of MSK, has been named to the  2021  City & State’s